Quality-of-Life Outcomes Among Patients Achieving High-Threshold Facial or Total Body Repigmentation With Ruxolitinib Cream in Nonsegmental Vitiligo. J of Skin. 2026;10(2):s753. doi:10.25251/r559dc08